|
|
Volumn 50, Issue 3, 2015, Pages 209-216
|
|
Efficacy/safety of ranibizumab monotherapy or with laser versus laser monotherpay in DME
a
b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
RANIBIZUMAB;
ANGIOGENESIS INHIBITOR;
VASCULOTROPIN A;
VEGFA PROTEIN, HUMAN;
ADULT;
ARTICLE;
CELLULITIS;
CENTRAL RETINAL THICKNESS;
CONGESTIVE HEART FAILURE;
CONJUNCTIVAL HEMORRHAGE;
CONTROLLED STUDY;
DIABETIC MACULAR EDEMA;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
DRUG WITHDRAWAL;
FEMALE;
HUMAN;
INCIDENCE;
INSULIN DEPENDENT DIABETES MELLITUS;
INTRAOCULAR PRESSURE ABNORMALITY;
ISCHEMIC COLITIS;
LASER COAGULATION;
MACULAR EDEMA;
MAJOR CLINICAL STUDY;
MALE;
MONOTHERAPY;
MULTICENTER STUDY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OPTICAL COHERENCE TOMOGRAPHY;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
RHINOPHARYNGITIS;
SIDE EFFECT;
VISUAL ACUITY;
VISUAL FUNCTION QUESTIONNAIRE 25;
VISUAL IMPAIRMENT;
VITREOUS HEMORRHAGE;
AGED;
ANTAGONISTS AND INHIBITORS;
CLINICAL TRIAL;
COMPARATIVE STUDY;
DIABETIC RETINOPATHY;
FLUORESCENCE ANGIOGRAPHY;
INTRAVITREAL DRUG ADMINISTRATION;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
PATHOPHYSIOLOGY;
PHASE 3 CLINICAL TRIAL;
PHYSIOLOGY;
PROCEDURES;
QUALITY OF LIFE;
RETINA;
SICKNESS IMPACT PROFILE;
TREATMENT OUTCOME;
AGED;
ANGIOGENESIS INHIBITORS;
COMBINED MODALITY THERAPY;
DIABETIC RETINOPATHY;
FEMALE;
FLUORESCEIN ANGIOGRAPHY;
HUMANS;
INTRAVITREAL INJECTIONS;
LASER COAGULATION;
MACULAR EDEMA;
MALE;
MIDDLE AGED;
QUALITY OF LIFE;
RANIBIZUMAB;
RETINA;
SICKNESS IMPACT PROFILE;
SURVEYS AND QUESTIONNAIRES;
TOMOGRAPHY, OPTICAL COHERENCE;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
|
|
EID: 84930154325
PISSN: 00084182
EISSN: 17153360
Source Type: Journal
DOI: 10.1016/j.jcjo.2014.12.014 Document Type: Article |
|
Times cited : (32)
|
|
References (12)
|
